Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
2.090
-0.070 (-3.24%)
At close: Jul 22, 2026, 4:00 PM EDT
2.100
+0.010 (0.48%)
Pre-market: Jul 23, 2026, 4:56 AM EDT
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $161.19 million as of July 23, 2026. Its market cap has increased by 2,199.87% in one year.
Market Cap
161.19M
Enterprise Value
119.65M
1-Year Change
2,199.87%
Ranking
Category
Stock Price
$2.09
ChartMarket Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $161.19M, an increase of 395.01%. That is a compound annual growth rate of 42.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 161.19M | 45.97% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Cognition | 170.60M |
| Korro Bio | 169.18M |
| YD Bio | 168.87M |
| OnKure Therapeutics | 168.85M |
| Karyopharm Therapeutics | 167.71M |
| Arcturus Therapeutics Holdings | 167.70M |
| Alector | 166.54M |
| Innate Pharma | 166.14M |